Low-Concentration Atropine Eye Drops for Myopia Progression
Asia Pac J Ophthalmol (Phila)
.
2023 Jul-Aug;12(4):345-346.
doi: 10.1097/APO.0000000000000617.
Epub 2023 Jun 28.
Authors
Jason C Yam
1
2
3
4
5
6
,
Jost B Jonas
7
8
9
,
Dennis S C Lam
10
11
Affiliations
1
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
2
Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China.
3
Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China.
4
Hong Kong Eye Hospital, Kowloon, Hong Kong, China.
5
Department of Ophthalmology, Hong Kong Children's Hospital, Hong Kong, China.
6
Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong, China.
7
Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
8
Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland.
9
Privatpraxis Prof Jonas und Dr Panda-Jonas, Heidelberg, Germany.
10
The International Eye Research Institute of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China.
11
The C-MER Dennis Lam & Partners Eye Center, C-MER International Eye Care Group, Hong Kong, China.
PMID:
37523423
DOI:
10.1097/APO.0000000000000617
No abstract available
Publication types
Editorial
MeSH terms
Atropine* / therapeutic use
Disease Progression
Humans
Mydriatics
Myopia* / drug therapy
Ophthalmic Solutions
Refraction, Ocular
Substances
Atropine
Ophthalmic Solutions
Mydriatics